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Abstract
Background. The CYP11B2 gene as the main controller of aldosterone plasma activity is likely to be responsible 
as for the BP level as for the expression of different traits of hypertensive cardiac remodeling such as increased left 
ventricular mass and myocardial fibrosis. The main objective of our study was to define the differences in myocardial 
remodeling depending on CYP11B2 gene polymorphism. It was shown that some special techniques of echocardiog-
raphy such as the assessment of inappropriate left ventricular mass and myocardial echoreflectivity proved additional 
information in patients with hypertensive heart disease. That’s why these techniques were used for a more precise 
assessment of hypertensive cardiac remodeling.
Material and methods. Our study involved 150 males aged 45–60 years. They were divided into three groups: 
Group 1–50 patients with normal BP without any echocardiographic abnormalities, Group 2–52 patients with es-
sential hypertension without left ventricular hypertrophy, and Group 3–48 patients with essential hypertension and 
left ventricular hypertrophy.
Results. It was found that in patients with inappropriate LVM the prevalence of CC genotype was almost twice 
higher than among those with appropriate LVM. On the other hand, hypertensive patients with CC genotype and 
LVH demonstrated higher echoreflectivity parameters.
Conclusions. We assume that CC polymorphism of CYP11B2 may be an indicator of more expressed signs of hy-
pertensive cardiac remodeling, in particular myocardial hypertrophy and myocardial fibrosis, in males with essential 
hypertension.
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Introduction
The CYP11B2 gene as the main controller of aldo-
sterone plasma activity is likely to be responsible 
for the BP level and expression of different traits of 
hypertensive cardiac remodeling. The main objective 
of our study was to define the differences in myo-
cardial remodeling depending on CYP11B2 gene 
polymorphism.
The increased left ventricular mass or left ven-
tricular hypertrophy (LVH) remains the most often 
mentioned trait of hypertensive remodeling. A huge 
number of clinical trials confirmed the negative in-
fluence of LVH on the prognosis of essential hyper-
tension. There is also some evidence that the left 
ventricular mass inappropriate to the BP level has 
additional negative predictive meaning [1–3]. 
Myocardial fibrosis is also an essential trait of hy-
pertensive heart disease, but is more difficult to reveal 
compared with LVH. Changes in myocardial density 
that are following fibrosis could be detected by analy-
sis of echoreflectivity. This technique is one of the 
possible approaches for the quantitative estimation of 
myocardial fibrosis. Echoreflectivity has been shown 
to have a strong correlation with collagen volume 
fraction [4]. Therefore, the echoreflectivity analysis 
was chosen for the assessment of myocardial fibrosis. 
Material and methods
The study involved men who were the ambulatory 
patients of Vinnytsia Regional Dispensary. The sam-
ple size of the patients with EH was calculated using 
Altman nomogram. The statistical power b was set 
as 0.85 and p as 0.05. The minimal difference in 
LVM that needed to be determined in groups with 
different genotypes was accepted as 10 g/m2.7 with the 
known mean SD approximately equal to 16 g/m2.7. 
Based on such parameters, the minimal sample size 
was determined as 90 persons.
The protocol of the study was approved by the 
local ethics committee. The informed consent was 
mandatory for all participants. Between 2016 and 
2017, 654 patients with EH aged 45–60 years were 
screened to identify 100 patients with EH. Among 
them, 58 had no irreversible target organs damages 
and 42 had left ventricular hypertrophy (LVH). Mean 
duration of the disease in patients with hypertension 
was 12.7 years with no substantial difference depend-
ing on LVH presence. Three BP measurements were 
performed at the first visit with 1–2 min interval 
between them. Additional measurements were made 
if the first two readings differed by >  10 mm Hg. 
The average of the last two BP readings was recorded. 
BP was measured in both arms at the first visit to 
detect possible between-arm differences. Then the 
arm with the higher value used as the reference. Di-
agnosis of hypertension was established according to 
the ESC recommendations (2018).  
The control group consisted of 50 normoten-
sive males of the same age without any pathological 
changes detected by echocardiography (ECG). The 
criteria for exclusion from the study were as follows:
• congenital or acquired heart defects;
• systemic connective tissue diseases;
• endocrine diseases;
• chronic kidney disease;
• secondary arterial hypertension;
• myocardial disease and heart failure, not associ-
ated with arterial hypertension;
• pulmonary arterial hypertension;
• hemodynamically significant arrhythmias (atrial 
fibrillation or flutter, AV block of 2nd and 3rd de-
gree, high-grade premature beats);
• unsatisfactory ultrasound visualization of the 
heart;
• type 1 DM or uncontrolled type 2 DM;
• unstable or variant angina at the day of inclusion.
The patients included in the study did not receive 
antihypertensive therapy (treatment-naive patients or 
those with a temporary pause in treatment for more 
than 1 month). Each participant underwent the fol-
lowing assessments: office blood pressure measure-
ment, echocardiography with echoreflectivity analy-
sis, and determination of the C-344T polymorphism 
of the aldosterone synthase gene CYP11B2.
Basic measurements of left ventricle such as end-
diastolic and end-systolic dimensions (EDD and 
ESD), left ventricular mass, indexed by the body 
height2.7 (LVMI), ejection fraction (EF), and rela-
tive wall thickness (RWT) were obtained by echo-
cardiography. Echocardiography was performed us-
ing “Sigma 5000” equipment (Kontron Medical, 
France). Based on echocardiography measurements 
the appropriateness of the left ventricular mass to 
the level of arterial pressure was determined by the 
formula proposed by De Simone et al. [1]:
LVMp = 55.37 + 6.64 × height (m)2,7 + 0.64SW 
– 18.07 × gender (g)
where LVMp is a predicted LVM, SW is a stroke work 
calculated by the formula: SW = SBP × SV × 0.0144, 
and the gender is 1 for men and 2 for women. 
In the case of exceeding the predicted values, the 
mass of the myocardium was considered as inap-
propriate.
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Simultaneously with the standard ECG, we lo-
cated 2 representative areas 20 × 10 mm in size (one 
— in the interventricular septum and another — in 
an LV posterior wall) on the images in the parasternal 
long axis view and saved them for the future process-
ing. During the processing, the broadband (BB) of 
the black and white spectrum and mean color scale 
value (MCSV) of chosen regions was calculated by 
“Image J” software in the offline mode. Figure 1 
demonstrates an example of such processing of the 
image. A more detailed description of this technique 
was published in [5].
According to majority of the sources, these 
parameters are the most reliable echoreflectivity 
markers of myocardial fibrosis. In an experimen-
tal study, its correlation with collagen volume 
fraction measured by biopsy was as high as 0.72 
(p = 0.03) [4]. 
The polymorphism of the CYP11B2 gene was de-
termined in venous blood samples of all participants 
by the PCR method.
Genomic DNA was extracted using a set of re-
agents for the extraction of genomic DNA from 
a blood sample (LLC “NPF Synthol”, Russia). Poly-
morphic regions of CYP11B2 gene were amplified by 
a polymerase chain reaction. The final volume of the 
reaction mixture was 25 μl and consisted of: 
• specific oligonucleotide primers: 5’-CAG GAG 
GAG ACC CCA TGT GAC-3’; 5’-CCT CCA 
CCC TGT TCA GCC C-3’; 
• 2.5 μl of 10x buffer for amplification; 
• 2 mM of magnesium chloride; 
• 0.2 mM of mixture of deoxynucleotide triphos-
phates (dNTP); 
• 2.5 units of Taq DNA polymerase; 
• 20–50 ng of genomic DNA. 
25 μl of mineral oil was poured into the test tubes.
The amplification was performed on the “Tertsik” 
amplifier (LLC “DNA-Technology”, Russia) using 
the amplification program, which includes the initial 
denaturation of 35 cycles at a temperature 94°C dur-
ing 5 minutes.
For the identification of the alleles, we carried out 
a restrictive analysis of the amplicons using endo-
nuclease restriction HaeIII (SibEnzyme, Russia) at 
37°C.
The cleavage products of the polymorphic sites of 
CYP11B2 gene were detected by electrophoresis in 
5% agarose gel (Agarose SFR, AMRESCO, USA) in 
a single TBE buffer (50 mM Tris-H3BO3 and 2 mM 
EDTA, pH 8.0) for 1 hour at 3–4 V per 1 cm of gel. 
PbR322/AluI was used as a DNA marker of molecu-
lar weight. Gels were stained with ethidium bromide, 
followed by visualization of results with UV-light.
Results and discussion
A total of 50 men with normal blood pressure and 
100 patients with AH were examined. Among the 
latter, 58 participants had hypertension without any 
damages of the target organs and, respectively, had 
normal LVM. Other 42 patients had hypertension 
with the ECG signs of LV hypertrophy, established 
based on the values of LVM index ≥ 50 g/m2.7. The 
results of anthropometry and standard echocardiog-
raphy are presented below (Tab. I).
The groups did not differ in age or height, but 
there were significant between-group differences in 
body mass (p < 0.001 by ANOVA test): the lowest 
values were observed in Group 1, and the highest 
— in Group 3 (Fig. 2). The same trend was seen for 
mean SBP and DBP values (p < 0.001) (Fig. 3).
In contrast, changes in LVM differed dramati-
cally: the indexed mean values of LVM were almost 
the same in Group 1 and Group 2, while in Group 
3 they were substantially higher (Fig. 3). Similar pat-
tern of RWT changes was observed. 
 0 255
Figure 1. Analysis of echoreflectivity. The left panel shows an left 
ventricle (LV) image with the region of interest (ROI) marked by 
a yellow rectangle. The right panel shows the grayscale spectrum 
of the ROI
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We revealed that mean values of LVMp calculat-
ed using the formula (1) increased relatively evenly, 
while mean actual LVMI values changed unevenly 
and the differences between Group 3 and Group 2 
were much more prominent and significant com-
pared with the differences between Group 2 and 
Group 1 group (Fig. 4).
We noticed that despite very similar mean BP 
values in Group 2 and Group 3 (Fig. 3), Group 3 
had the substantially greater LVM (Fig. 4). Moreover, 
the difference between actual LVM and LVMp in 
Group 2 was not significant [172.9 (34.9) vs. 162.4 
(25.7) g; p > 0.05] while in Group 3 LVM was sub-
stantially higher than LVMp [287.4 (53.9) vs. 189.4 
(37.8) g, p < 0.001 by the Wilcoxon paired test]. We 
believe that this is probable evidence of an intrinsic 
Table I. Anthropometry and echocardiography measurements in Groups 1, 2 and 3
NT (Group 1)
M (SD) 
n = 50
EH (Group 2)
M (SD)
n = 58
EH + LVH (Group 3)
M (SD)
n = 42
Mean age (y.) 49.4 (5.0) 49.6 (5.8) 49.2 (5.8)
Height [cm] 175.1 (11.4) 176.5 (6.8) 178.4 (5.5)
Weight [kg] 81.0 (14.0) 94.7 (19.2) 103.6 (16.8)
SBP [mm Hg] 124.5 (16.4) 151.4 (18.2) 160.1 (23.0)
DBP [mm Hg] 76.1 (9.9) 92.3 (12.0) 96.1 (13.8)
EDD [mm] 48.6 (4.6) 48.9 (4.9) 52.1 (5.2)
ESD [mm] 32.7 (4.1) 33.3 (4.7) 34.3 (4.9)
EF (%) 60.5 (7.8) 59.8 (7.7) 61.9 (9.8)
LVM [g/m2] 36.4 (14.5) 37.3 (7.0) 60.3 (12.0)
RWT 0.39 (0.06) 0.41 (0.09) 0.52 (0.11)
NT — normotension; EH — essential hypertension; EH + LVH — essential hypertension and left ventricular hypertrophy; SBP — systolic blood pressure; DBP — diastolic blood pressure; EDD — end-diastolic dimen-
sion; ESD — end systolic dimension; EF — ejection fraction; LVM — left ventricular mass; RWT — relative wall thickening
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Figure 2. Means of body mass and 95% confidence interval (CI) 
in three groups of patients
Figure 3. The average values and 95% confidential interval (CI) of systolic blood pressure (SBP) (A) and diastolic blood pressure (DBP) (B) 
in three groups of patients
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(genetic?) difference between patients with and with-
out LVH. Therefore, some additional markers are 
required for more accurate prediction of appropriate 
LVM in these patients.
The distribution of CYP11B2 polymorphism was 
almost the same in patients with normal BP and with 
EH regardless of LVH presence (Tab. II).
However, when all the patients were re-divided 
depending on predicted values of LVM, the differ-
ences in distribution become evident (Fig. 6).
As it can be seen in the diagrams, the prevalence 
of CC polymorphism of CYP11B2 gene in males 
with inappropriate LVM was almost twice higher 
than among those with appropriate LVM. These dif-
ferences were statistically significant by c2 criterion 
(p = 0.015).
Increasing echoreflectivity may be a marker of dis-
orders the intrinsic architecture of myocardium. In 
theory, an increase in high-density elements of myo-
cardium such as collagen fibers leads to the increase 
in ultrasound waves reflections that could be de-
tected by the device capable to detect the difference 
in power of waves moving forward and backward, 
so-called backscatter. For more accurate estimation 
of backscatter, 2 or more myocardium regions were 
used for averaging of the results. In addition, myo-
cardium backscatter is often compared with back-
scatter of the toughest heart structures of the same 
patient such as pericardium (calibration of backscat-
ter). That’s why this method is known as integrated 
calibrated backscatter.
Table II. The distribution of CYP11B2 polymorphism in normotensive patients, hypertensive patients and hypertensive patients with left 
ventricular hypertrophy
Groups CC TC TT
c2 p
NT (n = 50) 12 24 14
EH (n = 58) 12 29 17 0.23 0.88
EH + LVH (n = 42) 7 24 11 0.77 0.68
c2 — the significance of differences when compared EH and EH + LVH groups with NT group; NT — normotension; EH — essential hypertension; EH + LVH — essential hypertension and left ventricular hypertrophy
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Figure 4. Average indexed left ventricular mass (LVM) and 95% 
confidence interval (CI) in three groups of patients
Figure 5. Means and 95% confidence interval (CI) for actual (A) and predicted (B) indexed left ventricular mass (LVM)
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Table III. Mean echoreflectivity parameters in Groups 1, 2 and 3. Data are presented as means (SD)
Parameter Group 1 Group 2 Group 3
MCSV 62.3 (28.5) 59.9 (32.4) 74.5 (36.5)
BB 105.3 (51.5) 109.0 (37.0) 135.4 (22.8)
MCSV — mean color scale value; BB — broadband of the black and white spectrum
Another way of reflected signal estimation is 
processing of grayscale images of myocardium by 
the external software in the offline mode such as 
“Image  J”. Since the gray scale has 256 standard 
gradations represented by a certain number of pixels, 
the general image information can be represented 
as a column (frequency) graph, which displays the 
number of pixels for each tint. The most useful pa-
rameters are the mean color scale value (MCSV) and 
broadband (BB). As with the integrated calibrated 
backscattering analysis, in order to obtain more ob-
jective information, a minimum of 2 regions of 
interest (ROI) were chosen: one is in the middle of 
the interventricular septum, and the other — in the 
posterior wall of left ventricle. The values of MCSV 
and/or BB could be calculated as a mean of these 
two readings.
Echoreflectivity was estimated in all of the patients 
in the above-mentioned manner. Obtained results 
are shown below (Tab. III).
In patients with EH and LVH (Group 3) the 
values of MCSV were higher than in normotensive 
and hypertensive patients without LVH, although 
the statistical significance of the differences was low 
(p = 0.066). The range of the grayscale spectrum 
(BB) in patients with LVH was significantly higher 
(p < 0.001) than in other study groups (Fig. 7) and 
looked similar to the trend of LVM (Fig. 4). This fact 
supports our suggestion about intrinsic differences 
between patients with and without LVH.
Echoreflectivity was also analyzed in groups cre-
ated on the basis of the predicted values of LVM 
and having appropriate or inappropriate LVM. As 
it was mentioned earlier, these groups consisted of 
45 and 105 men respectively. The mean values of 
MCSV and BB were higher in males with inappro-
priate LVM than in those with appropriate LVM 
(Fig. 8).
At the present time, we know that hypertensive 
cardiac remodeling includes the increase in the 
thickness of muscle fibers and myocardial mass but 
also changes in microcirculation with the exten-
sion of relative coronary insufficiency and myocar-
dial fibrosis. The detection of exceed in myocardial 
mass is a relatively simple diagnostic task. How-
ever, myocardial fibrosis and coronary failure often 
remain unnoticed, which leads to the underestima-
tion of their role in hypertensive heart disease. On 
the other hand, the old question of whether LVH 
is always a pathological process in persistent hyper-
tension, and where the borderline passes between 
compensatory and pathological hypertrophy, still 
remains open. Our recent results allow assuming 
that the determination of the appropriateness of 
the left ventricular myocardial mass to the level of 
blood pressure could be useful not only concern-
Appropriate LVM
(n = 45)
Inappropriate LVM
(n = 105)
46.7
39.0
17.8
39.0
35.6
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Figure 6. Frequencies (%) of CYP11B2 gene polymorphisms in patients with appropriate (A) and inappropriate (B) left ventricular mass (LVM)
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ing the severity of hypertrophy but also concerning 
echoreflectivity that is considered a marker of myo-
cardial fibrosis. In this case, a greater prevalence 
of the inappropriate LVM in patients with such 
a structure of the gene CYP11B2 could indicate on 
a genetic predisposition for more expressive mani-
festations of hypertensive heart disease at the same 
level of blood pressure. Therefore, we can assume 
that the CC polymorphism of the CYP11B2 gene 
could serve as a marker of more expressed remodel-
ing, including myocardial fibrosis and myocardial 
hypertrophy.
The method used to determine the appropriate 
mass of the left ventricle in this study showed al-
most linear growth of the calculated values in the 
study groups, while the real values had a character 
that resembles an exponential curve. Therefore, 
despite the proven additional predictive value of 
the appropriate LV mass, this method requires ad-
aptation to real practice. Another conclusion is that 
the mass of left ventricle does not depend directly 
on the level of BP. Consequently, other factors, 
responsible for the hypertensive cardiac remodel-
ing, besides the hemodynamic load, may be hy-
pothesized. There is growing evidence that at least 
some of these factors may be of genetic origin and 
aldosterone synthase gene could be among them. 
At least, the data obtained are not in controversy 
with such a hypothesis, but to some extent they 
support it.
Figure 8. Means and 95% confidence interval (CI) for mean color scale (MCSV) (A) and broadband of the black and white spectrum (BB) (B) 
in groups with appropriate and inappropriate left ventricular mass (LVM)
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Figure 7. Means and 95% confidence interval (CI) for mean color scale (MCSV) (A) and broadband of the black and white spectrum (BB) (B) 
in three groups of patients
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Therefore, the next step may be to compare the 
mass and myocardial reflectivity in patients with dif-
ferent CYP11B2 polymorphisms, standardized for 
other parameters and risk factors.
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